tiprankstipranks
Trending News
More News >
Aarti Pharmalabs Limited (IN:AARTIPHARM)
:AARTIPHARM
India Market

Aarti Pharmalabs Limited (AARTIPHARM) Financial Statements

Compare
1 Followers

Aarti Pharmalabs Limited Financial Overview

Aarti Pharmalabs Limited's market cap is currently ₹69.01B. The company's EPS TTM is ₹3.081; its P/E ratio is 28.78; and it has a dividend yield of 0.67%. Aarti Pharmalabs Limited is scheduled to report earnings on November 9, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 21.15B₹ 18.16B₹ 19.45B₹ 11.92B₹ 0.00
Gross Profit₹ 9.87B₹ 3.91B₹ 4.14B₹ 3.12B₹ 0.00
Operating Income₹ 3.77B₹ 2.81B₹ 2.80B₹ 1.65B₹ -45.96K
EBITDA₹ 4.74B₹ 3.91B₹ 3.44B₹ 1.98B₹ -45.96K
Net Income₹ 2.72B₹ 2.17B₹ 1.93B₹ 1.22B₹ -45.96K
Balance Sheet
Cash & Short-Term Investments₹ 562.06M₹ 940.33M₹ 631.11M₹ 832.73M₹ 2.50M
Total Assets₹ 29.06B₹ 25.82B₹ 22.44B₹ 20.40B₹ 2.50M
Total Debt₹ 4.13B₹ 2.85B₹ 2.15B₹ 3.41B₹ 173.00K
Net Debt₹ 4.04B₹ 2.62B₹ 2.03B₹ 2.58B₹ -2.33M
Total Liabilities₹ 9.16B₹ 8.25B₹ 6.86B₹ 6.53B₹ 232.71K
Stockholders' Equity₹ 19.90B₹ 17.57B₹ 15.58B₹ 13.86B₹ 2.27M
Cash Flow
Free Cash Flow₹ -704.76M₹ 175.69M₹ 1.30B₹ -1.85B₹ 0.00
Operating Cash Flow₹ 3.32B₹ 2.16B₹ 2.50B₹ -437.04M₹ 0.00
Investing Cash Flow₹ -4.14B₹ -2.15B₹ -1.58B₹ -1.39B₹ 0.00
Financing Cash Flow₹ 654.35M₹ 97.23M₹ -1.63B₹ 2.60B₹ 0.00
Currency in INR

Aarti Pharmalabs Limited Earnings and Revenue History

Aarti Pharmalabs Limited Debt to Assets

Aarti Pharmalabs Limited Cash Flow

Aarti Pharmalabs Limited Forecast EPS vs Actual EPS